First physicians to implant BioProtect Balloon in US describe benefits of the spacer

In this interview, Shawn Zimberg, MD, and Dean Laganosky, MD, discuss the BioProtect Balloon Transplant System, a rectal spacer that received FDA clearance in August 2023 for use during prostate cancer radiation.1 Zimberg–a radiation oncologist and medical director at Advanced Radiation Centers (ARC) of New York, a division of Integrated Medical Professionals (IMP)–performed the first procedures in the US in October 2023. Laganosky–a urologist with MidLantic Urology (MLU)–performed his first procedures in November 2023, becoming the first to do so in Pennsylvania. Both IMP and MLU are affiliates of Solaris Health.

Read the full article.